CN Patent

CN102058517A — 一种帕潘立酮缓释剂及其制备方法

Assigned to TAIZHOU WANQUAN PHARM-TECH Co Ltd · Expires 2011-05-18 · 15y expired

What this patent protects

本发明涉及一种帕潘立酮缓释剂型及其制备方法，该缓释剂型包含缓释骨架、膜控包衣层、稀释剂、粘合剂、润滑剂。该缓释剂型能在足够长的时间内以持续的恒定速率释放，血药浓度平稳，维持在一个稳定有效的范围内，降低了给药频率，从而使药物达到长效作用。

USPTO Abstract

本发明涉及一种帕潘立酮缓释剂型及其制备方法，该缓释剂型包含缓释骨架、膜控包衣层、稀释剂、粘合剂、润滑剂。该缓释剂型能在足够长的时间内以持续的恒定速率释放，血药浓度平稳，维持在一个稳定有效的范围内，降低了给药频率，从而使药物达到长效作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102058517A
Jurisdiction
CN
Classification
—
Expires
2011-05-18
Drug substance claim
No
Drug product claim
No
Assignee
TAIZHOU WANQUAN PHARM-TECH Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.